DISCOUNT-ZERTIFIKAT - QIAGEN Stock

Certificat

DE000DQ0B2R3

Real-time Bid/Ask 07:05:00 2024-07-03 EDT
24.45 EUR / 24.47 EUR -0.04% Intraday chart for DISCOUNT-ZERTIFIKAT - QIAGEN
Current month+0.08%
1 month+0.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-03 24.47 0.00%
24-07-02 24.47 +0.12%
24-07-01 24.44 -0.04%
24-06-28 24.45 +0.04%
24-06-27 24.44 -0.16%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 04:13 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying QIAGEN N.V.
Issuer DZ BANK
WKN DQ0B2R
ISINDE000DQ0B2R3
Date issued 2024-02-08
Cap 25
Last trading day 2024-12-20
Maturity 2024-12-20 (170 Days)
Parity 1 : 1
Emission price 24.1
Emission volume N/A
Payment day 2024-12-31
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 35.44 %
Sideways yield 2.208 %
Sideways yield pa 4.740 %
Outperformance point 38.72
Break even 24.46 €
Highest since issue 24.48
Lowest since issue 24.05
Spread 0.02
Spread %0.08%
Distance Cap 12.74
Distance Cap %+33.75%
Max. earning 0.54
Max. earning % 2.208 %

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Sector
-
More about the company

Ratings for Qiagen N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Qiagen N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
40.7 USD
Average target price
50.37 USD
Spread / Average Target
+23.75%
Consensus